Reducing Perioperative Cardiac Risk in Noncardiac Surgery: A Time to Delineate Simpler Strategies?

Abstract

References

Goldman L. , Caldera DL , Nussman SR , et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 297:845, 1977

Mangano DT , Browner WS , Hollenberg M. , et al. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing non-cardiac surgery: The Study of Perioperative Ischemia Research Group. N Engl J Med 323:1781, 1990

Mantha S. , Roizen MF , Barnard J. , et al. Relative effectiveness of four preoperative tests for predicting adverse cardiac outcomes after vascular surgery: a meta-analysis. Anesth Analg 79:422, 1994

Eagle KA , Brundage BH , Chaitman BR , et al. Guidelines for perioperative cardiovascular evaluation for noncardiac surgery: Report of the American College of Cardiology/ American Heart Association Task Force on Practical Guidelines (Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 27:910, 1996

Leenen Fhh. Cardiovascular consequences of sympathetic hyperactivity. Can J Cardiol 15:2A, 1999 (Suppl)

Meredith IT , Broughton A. , Jennings GL , et al. Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. N Engl J Med 325:618, 1991

Schwartz PJ , La Rovere MT, Vanoli E. Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation 85:177, 1992 (Suppl)

Reiter MJ , Reiffel JA Importance of beta-blockade in the therapy of serious ventricular arrhythmias . Am J Cardiol 82:91, 1998

Singh BN Antiarrhythmic drugs: Re-orientation of recent developments in the control of disorders of cardiac rhythm. Am J Cardiol 81:3D, 1998

10.

Yusuf S. , Peto R. , Lewis J. , et al. Beta-blockade during myocardial infarction: An overview of randomized trials. Prog Cardiovasc Dis 27:335, 1985

11.

Yusuf S. , Wittes J. , Friedman L. Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction. JAMA 260:2088, 1988

12.

Hallstrom AP , Cobb LA , Yu BH , et al. An antiarrhythmic drug experience in 941 patients resuscitated from an initial cardiac arrest between 1970 and 1985. Am J Cardiol 68:1025, 1991

13.

Schwartz PJ The idiopathic long QT interval syndrome: Progress and questions. Am Heart J 109:399, 1985

14.

Tan HL , Hou CJ , Lauer MR , et al. Electrophysiologic mechanisms of the long QT interval syndromes and torsade de pointes. Ann Int Med 122:701, 1995

15.

Steinbeck G. , Andersen D. , Bach P. , et al. A comparison of electrophysiologically guided antiarrhythmic drug therapy with beta-blocker therapy to patients with symptomatic sustained tachyarrhythmias. N Engl J Med 327:987, 1992

16.

Wiesfeld AC , Crijns HJ , Tuininga YS , et al. Beta adrenergic blockade in the treatment of sustained ventricular tachycardia or ventricular fibrillation. Pacing & Clin Electrophysiol 19:1026, 1996

17.

Multicentre international study : Supplementary report. Reduction in mortality after myocardial infarction with long-term beta-adrenoceptor blockade. Br Med J 12:419, 1997.

18.

Beta-blocker Heart Attack Trial Research Group : A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA 247:1707, 1982

19.

Metoprolol in acute myocardial infarction (MIAMI). A randomized placebo-controlled international trial. The MIAMI Trial Research Group. Eur Heart J 6:199, 1985

20.

ISIS-1 Collaborative Group. Mechanisms for the early mortality reduction produced by beta-blockade started early in acute myocardial infarction: ISIS-1. ISIS-1 (First International Study of Infarct Survival). Lancet 1:922, 1988

21.

Kendall MJ , Lynch KP , Hjalmarson A. , et al. Beta-blockers and sudden cardiac death. Ann Intern Med 123:358, 1995

22.

Hjalmarson A. Effects of beta blockade on sudden cardiac death during acute myocardial infarction and the postinfarction period. Am J Cardiol 80:35J, 1997

23.

Avanzini F. , Zuanetti G. , Latini R. , et al. Use of beta-blocking agents in secondary prevention after myocardial infarction: A case for evidence-based medicine? GISSI experience, 1984-1993. The Gruppo Italiano di Studio sulla Sopravvivenza nell'Infarto Miocardico (GISSI) Investigators. Eur Heart J 18:1447, 1997

24.

Pfisterer M. , Cox JL , Granger CB , et al. Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: The GUSTO-I experience. Global Utilization of Streptokinase and TPA (alteplase) for Occluded Coronary Arteries. J Am Coll Cardiol 32:634, 1998

25.

Gottlieb SS , McCarter RJ , Vogel RA Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction . N Engl J Med 339:4889, 1998

26.

Chadda K. , Goldstein S. , Byington R. , et al. Effect of propranolol after acute myocardial infarction in patients with congestive heart failure. Circulation 73:5003, 1986

27.

Packer M. , Colucci WS , Sackner-Bernstein JD , et al. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The Precise Trial. Circulation 94:2793, 1996

28.

Packer M. , Bristow MR , Cohn JN The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334:1349, 1996

29.

Waagestein F. , Bristow MR , Swedberg K. , et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet 342:1441, 1993

30.

CIBIS Investigators and Committees. A randomized trial of beta-blockade and heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation 90:1765, 1994

31.

MERIT-HEFT Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). Lancet 353:2001, 1999

32.

CIBIS-II Investigators and Committees. The cardiac insufficiency treated with bisoprolol. CIBIS II). Lancet 353:9, 1999

33.

Australia-New Zealand Heart Failure Research Collaborative Group. Randomized, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischemic heart disease. Lancet 349:375, 1997

34.

Australia-New Zealand Heart Failure Research Collaborative Group. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Circulation 92:212, 1995

35.

Stone JG , Foex P. , Sear JW , et al. Myocardial ischemia in untreated hypertensive patients: Effect of a single small dose of beta-adrenergic blocking agent. Anesthesiology 68:495, 1988

36.

Pasternack PF , Imparato AM , Baumann FG , et al. The hemodynamics of beta-blockade in patients undergoing abdominal aortic aneurysm repair. Circulation 76:III-1-III-7, 1987 (Suppl)

37.

Pasternack PF , Grossi EA , Baumann FG , et al. Beta-blockade to decrease silent myocardial ischemia during peripheral vascular surgery . Am J Surg 158:113, 1989

38.

Poldermans D. , Boersma E. , Bax JJ , et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med 341:1789, 1999

39.

Lee TH Reducing cardiac risk in noncardiac surgery. N Engl J Med 341:1838-1839, 1999

40.

Poldermans D. , Arnese M. , Fioretti PM , et al. Improved cardiac risk stratification in major vascular surgery with dobutamine-atropine stress echocardiography . J Am Coll Cardiol 26:648, 1995

41.

Davila-Roman VG , Waggoner AD , Sicard GA , et al. Dobutamine stress echocardiography predicts surgical outcome in patients with an aortic aneurysm and peripheral vascular disease. J Am Coll Cardiol 21:957, 1993

42.

Mangano DT , Browner WS , Hollenberg M. , et al. Association of perioperative myocardial ischemia with morbidity and mortality in men undergoing noncardiac surgery. N Engl J Med 323:1781, 1990

43.

Mangano DT Perioperative cardiac morbidity. Anesthesiology 72:153, 1990

44.

Mangano DT , Layug EL , Wallace A. , et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med 335:1713, 1996

45.

First International Study of Infarct Survival Collaborative Group. Randomized trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infraction: ISIS-1. Lancet 2:57, 1986

46.

Pepine CJ , Cohn PF , Deedwania PC , et al. Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life: The Atenolol Silent Ischemia Study. Circulation 90:762, 1994.

47.

Wallace A. , Layug B. , Tateo I. , et al. Prophylactic atenolol reduced post-operative myocardial ischemia . Anesthesiology 88:17, 1998

48.

Singh BN , Lopez B. , Sarma Jsm.

Significance and prevention of atrial fibrillation occurring after cardiac surgery: A time for fundamental change in strategy? J Cardiosc

Pharmacol Therapeut 3:259, 1998